SCHEMBL24854017

SCHEMBL24854017

CO[C@@H]1CCN([C@@H]2CCN(C(C)(C)C)C2)C1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.31
IRAK4 Q9NWZ3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24854369 1.00 HRH3 (0.31) HRH3IRAK4
SCHEMBL24854068 1.00 HRH3 (0.31) HRH3IRAK4
SCHEMBL24854370 1.00 HRH3 (0.31) HRH3IRAK4
SCHEMBL24854519 0.91 HRH3 (0.34) HRH3IRAK4
SCHEMBL24854517 0.91 HRH3 (0.34) HRH3IRAK4
SCHEMBL24854073 0.91 HRH3 (0.31) HRH3
SCHEMBL24854274 0.91 HRH3 (0.31) HRH3
SCHEMBL24854512 0.89 ATM (0.31)
SCHEMBL24854829 0.89 ATM (0.34) IRAK4
SCHEMBL23588614 0.89 ATM (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002382-A1 SPIRO RING-CONTAINING QUINAZOLINE COMPOUNDS Wigen Biomedicine Technology (shanghai) Co., Ltd. (CN) 2023-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002382-A1 SPIRO RING-CONTAINING QUINAZOLINE COMPOUNDS KRAS, NRAS, HRAS HRH3 2019/4885IRAK4 1415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.